Literature DB >> 1819036

[Studies on double-labelling method for determination of T lymphocyte subpopulations].

G X Shen1, W J Dai, X L Wang, N Su, H F Zhu, W X Ye, J W Li.   

Abstract

In order to determine the concurrent expression of DR and CD antigen of T lymphocyte surface markers, the fluorescence-rosette double-labelling technique was developed by employing monoclonal antibody against HLA-DR and sensitized sheep erythrocytes with OKT series of monoclonal antibodies against cell surface antigen. Its reliability was evaluated by comparison with two-step isolating technique for determining DR antigen of activated T lymphocyte subsets in 30 healthy volunteers. The result showed there was no statistic difference between results determined with two methods. The double-labelling technique was characterized by its samplity, no injury for cellular activity and ability for analysing the expression of the single antigen and double antigens on cell surface concurrently.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819036     DOI: 10.1007/BF02888161

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  4 in total

1.  A flow cytometric rosetting assay for the analysis of IgG-Fc receptor interactions.

Authors:  W B Tuijnman; J G Van de Winkel; P J Capel
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

2.  Studies on lymphocyte subpopulations and NK cell activities in epileptic patients.

Authors:  X L Wang; G X Shen; B Sun; N Su
Journal:  J Tongji Med Univ       Date:  1989

3.  Single laser flow cytometric detection of lymphocytes binding three antibodies labelled with fluorescein, phycoerythrin and a novel tandem fluorochrome conjugate.

Authors:  R Festin; A Björkland; T H Tötterman
Journal:  J Immunol Methods       Date:  1990-01-24       Impact factor: 2.303

4.  Three-color immunofluorescence analysis of mouse B-lymphocyte subpopulations.

Authors:  D R Parks; R R Hardy; L A Herzenberg
Journal:  Cytometry       Date:  1984-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.